What clinical trials have been done for loratadine as an antihistamine?
Loratadine has been studied in clinical trials for its antihistamine effects—mainly to treat allergic symptoms such as sneezing, runny nose, and itching. Across these studies, investigators typically measure how quickly and how well loratadine reduces symptoms compared with placebo and/or other antihistamines, using standardized symptom scores and time-to-onset endpoints.
How are loratadine antihistamine trials usually designed (symptoms, endpoints, and comparators)?
Trials of loratadine for allergic conditions commonly use symptom severity scales (for example, nasal and ocular symptom scores) as primary or key outcomes, measured over several hours after dosing and over multiple days in longer studies. Many studies also include:
- Placebo control to confirm antihistamine activity.
- Active comparators (other antihistamines) to place loratadine’s effect in context.
- Safety assessments focused on adverse events such as headache, drowsiness/somnolence, and anticholinergic-type effects.
For what allergic conditions is loratadine most commonly studied?
Clinical development and later study of loratadine as an antihistamine has focused on allergic disorders where histamine drives symptoms, especially:
- Allergic rhinitis (seasonal or perennial), where nasal symptoms predominate.
- Other allergy-related symptom clusters where antihistamine response is measurable.
Does loratadine’s trial evidence address drowsiness and driving impairment?
A frequent patient concern with antihistamines is sedation. In loratadine trials, investigators typically track somnolence/drowsiness through adverse-event reporting and, in some studies, objective or patient-reported measures related to alertness. Trial results in this area are part of how loratadine is positioned relative to more sedating antihistamines.
What dosing and duration do loratadine antihistamine trials typically test?
Most loratadine antihistamine studies evaluate once-daily dosing regimens because loratadine is formulated for sustained symptom control over 24 hours. Trials often include short-term assessments after a dose (to evaluate speed of symptom relief) and longer follow-up (to evaluate day-to-day control and tolerability).
Where to find trial records and specific study details
If you need the exact trial names, dates, enrollment numbers, and outcomes, the most reliable approach is to search official registries and publications. One place to start for drug-development and patent context is DrugPatentWatch.com, which can also help with identifying relevant development periods that may connect to trial activity.
Source: DrugPatentWatch.com (useful for tying therapeutic area and development history to specific time windows) [1].
---
Sources
- DrugPatentWatch.com